AngioWaveNet vs Assert-IQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AngioWaveNet

by Angiowave Imaging

Assert-IQ

by Abbott Medical

AI Verdict

AngioWaveNet is designed to improve vessel visualization in fluoroscopic angiograms during cardiac catheterization procedures. In contrast, Assert-IQ is an insertable cardiac monitor system focused on long-term, continuous monitoring and advanced arrhythmia detection. While both serve the cardiology domain with AI, they address distinct clinical needs: image enhancement during interventions versus long-term rhythm diagnostics.

Choose AngioWaveNet if…

Choose AngioWaveNet if your primary goal is to enhance the clarity and detail of fluoroscopic angiograms in real-time or near real-time within the cardiac catheterization lab. This tool is ideal for interventional cardiologists and vascular surgeons seeking improved visualization of blood vessels and anatomical structures during complex procedures, integrating seamlessly with existing cath lab equipment.

View AngioWaveNet →

Choose Assert-IQ if…

Choose Assert-IQ if you need a long-term, continuous cardiac monitoring solution for patients with suspected or diagnosed heart rhythm disorders. This insertable cardiac monitor is best suited for comprehensive arrhythmia detection and remote patient management over several years, providing proactive alerts and patient-logged symptoms to aid in diagnosis and treatment outside of acute procedural settings.

View Assert-IQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AngioWaveNet	Assert-IQ
Pricing	Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available.	Enterprise
Deployment	Cloud-based or on-premise/servers	Hybrid
FDA Status	1 AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet emphasizes seamless integration into existing Cath lab workflows, being vendor-agnostic and functioning as a DICOM endpoint. This design prioritizes ease of use for clinicians within their established environment, minimizing disruption. Assert-IQ's usability focuses more on the patient experience and remote monitoring infrastructure.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. AngioWaveNet directly enhances fluoroscopic angiograms for improved vessel visualization during cardiac procedures, aiding immediate diagnostic quality. Assert-IQ provides long-term, continuous cardiac monitoring with advanced arrhythmia detection, crucial for diagnosing and managing chronic heart rhythm disorders over extended periods. Their impact is critical in different phases of patient care.

Pricing & Value

AngioWaveNet

AngioWaveNet offers flexible pricing options, including annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs, with custom packages available. This transparency and adaptability suggest a more accessible and potentially cost-effective solution for various institutional sizes. Assert-IQ's 'enterprise' pricing, requiring direct contact with Abbott Medical, implies less transparency and potentially higher, negotiated costs.

Enterprise Readiness

Assert-IQ

Assert-IQ benefits from being a product of Abbott Medical, a large and established healthcare company with a long history and extensive infrastructure for supporting large health systems. While AngioWaveNet offers flexible deployment and vendor-agnostic integration, Abbott's backing typically translates to more robust enterprise-level sales, implementation, and long-term support resources. Both are FDA-cleared and HIPAA compliant, indicating foundational readiness.

Innovation

Assert-IQ

Assert-IQ demonstrates significant innovation by combining long-term continuous cardiac monitoring (up to 6 years) with advanced AI arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, and a comprehensive remote monitoring ecosystem. This integrated approach, including proactive clinician alerts and patient symptom logging, pushes the boundaries of cardiac rhythm management. AngioWaveNet's AI-powered image enhancement is innovative but focuses on improving an existing modality.

Support & Docs

Assert-IQ

Abbott Medical provides comprehensive support for Assert-IQ, including detailed clinician manuals, patient information guides, a dedicated remote care technical support team, and SyncUPu2122 Remote Monitoring Support for patient onboarding. While AngioWaveNet offers full onboarding support and staff training, the breadth and depth of established support from a large company like Abbott are generally more extensive for enterprise clients.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AngioWaveNet	Assert-IQ
Name	AngioWaveNet	Assert-IQ
Company	Angiowave Imaging	Abbott Medical
Description	FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows.	The Assert-IQ™ Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.
Tagline	AI Transforming Angiography	Advanced, long-term insertable cardiac monitoring for comprehensive arrhythmia detection.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Clinical Decision Support & Reference
Specialties	Cardiology, Interventional Radiology, Vascular Surgery	Cardiology, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and Assert-IQ.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a physician's existing clinical workflow, and what are their primary clinical applications?

AngioWaveNet integrates into existing Cath lab workflows as post-processing AI, enhancing fluoroscopic angiograms for improved vessel visualization during cardiac catheterization. Assert-IQ involves a minimally invasive insertion procedure and then provides long-term, continuous remote monitoring for advanced arrhythmia detection, aiding in the diagnosis and management of heart rhythm disorders.

What is the depth of integration with existing hospital imaging or data management systems, and how is patient data managed?

AngioWaveNet functions as a DICOM endpoint, allowing it to integrate with existing fluoroscopic angiography systems and PACS for image processing and storage. Assert-IQ utilizes a secure cloud-based data platform for remote monitoring data, with capabilities for data export to facilitate integration with other hospital systems.

How do these tools specifically improve diagnostic accuracy or patient management outcomes in their respective clinical contexts?

AngioWaveNet's AI-powered Spatiotemporal Enhancement Processing (STEPu2122) improves vessel visualization in fluoroscopic angiograms, potentially leading to clearer diagnostic insights during interventional procedures. Assert-IQ provides long-term continuous monitoring and advanced arrhythmia detection algorithms, enabling proactive clinician alerts and comprehensive diagnosis of suspected heart rhythm disorders over an extended period.

What is the expected learning curve for clinical staff, and what level of support is provided for implementation and ongoing use?

AngioWaveNet is designed to integrate with existing Cath lab workflows and is compatible with any fluoroscopic angiography system, suggesting a potentially minimal learning curve for image processing. Assert-IQ involves a minimally invasive insertion procedure and remote monitoring setup, which would require training for both the procedure and the use of its secure cloud-based data platform and alert system.

What specific security measures are in place to protect sensitive patient data beyond standard compliance requirements?

AngioWaveNet functions as a DICOM endpoint, implying adherence to secure image transfer protocols, and offers both cloud-based and on-premise deployment options for data control. Assert-IQ utilizes a secure cloud-based data platform for remote monitoring, employing Bluetoothu00ae Low Energy for data transmission and proactive clinician alerts, indicating robust data handling.

How well do these tools cater to different medical specialties, and what are the considerations for multi-site implementation?

AngioWaveNet is applicable across Cardiology, Interventional Radiology, and Vascular Surgery due to its angiography enhancement capabilities, and its cloud-based option could facilitate multi-site deployment. Assert-IQ primarily serves Cardiology and Internal Medicine for arrhythmia detection, and its remote monitoring and cloud platform are inherently designed to support patient management across multiple sites.

What is the expected time-to-value for each tool, and do they offer robust audit trail features for clinical decision-making?

AngioWaveNet can provide immediate value by enhancing vessel visualization during ongoing procedures in the cath lab. Assert-IQ provides long-term diagnostic value over up to 6 years of continuous monitoring, and its secure cloud-based platform would inherently log detected events and clinician interactions for audit purposes.